Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032344 | SCV001195651 | pathogenic | Tuberous sclerosis 2 | 2019-08-22 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 1-15 of the TSC2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 15 of the TSC2 gene. This is expected to result in an absent or disrupted protein product. Similar deletions has been observed in individuals affected with tuberous sclerosis (PMID:20498439, 17287951). Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). For these reasons, this variant has been classified as Pathogenic. |